iRhythm Holdings, Inc. (IRTC)
160.33
-4.46
(-2.71%)
USD |
NASDAQ |
Jan 23, 16:00
160.33
0.00 (0.00%)
After-Hours: 16:06
iRhythm Holdings Research and Development Expense (TTM): 82.64M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International, Inc. | 518.00M |
| Alphatec Holdings, Inc. | 76.78M |
| AtriCure, Inc. | 89.62M |
| Integra LifeSciences Holdings Corp. | 76.44M |
| Tandem Diabetes Care, Inc. | 198.42M |